NextCure, Inc. (NXTC) Social Stream



NextCure, Inc. (NXTC): $3.79

0.15 (+4.12%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NXTC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

NextCure Inc (NXTC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NextCure Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-14 6 $21 $10 $15 $4.86 208.64%
2021-11-15 6 $21 $11 $15.5 $4.86 218.93%
2021-12-03 6 $21 $7 $14.5 $4.86 198.35%
2021-12-13 5 $21 $7 $15.2 $4.86 212.76%
2022-01-11 6 $21 $7 $15.5 $4.86 218.93%
2022-02-04 6 $21 $7 $14.5 $4.86 198.35%
2022-03-04 6 $21 $7 $14.714 $4.86 202.76%
2022-03-13 7 $21 $7 $14.714 $4.86 202.76%

The Trend in the Analyst Price Target


NXTC's average price target has moved down $8.62 over the prior 14 months.

Over the past 49 weeks, NXTC's average upside potential has been 147.18%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 5 30 10 18.290 7.23 152.97%
2021-09-18 5 30 10 17.570 7.00 151%
2021-09-19 5 30 10 17.570 7.00 151%
2022-02-04 7 21 7 14.500 5.34 171.54%
2022-03-04 6 21 7 14.714 4.76 209.12%

NXTC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.86 4 1 1 0 0 7

The Trend in the Broker Recommendations


NXTC's average broker recommendation rating improved by 0.47 over the prior 120 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NXTC as an investment opportunity.

  • NXTC has a higher upside potential (average analyst target price relative to current price) than 794.27% of all US stocks.
  • In terms of how NextCure Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -684.22% of that group.
  • In the context of all US stocks, NextCure Inc's average analyst price target is greater than 143.92% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, NextCure Inc's number of analysts covering the stock is higher than 704.49% of them.

Stocks similar to NextCure Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NWBO, NUVL, and NRXP.

Is NXTC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6469 seconds.